Converting cancer genes into killer genes.
AUTOR(ES)
Da Costa, L T
RESUMO
Over the past decade, it has become clear that tumorigenesis is driven by alterations in genes that control cell growth or cell death. Theoretically, the proteins encoded by these genes provide excellent targets for new therapeutic agents. Here, we describe a gene therapy approach to specifically kill tumor cells expressing such oncoproteins. In outline, the target oncoprotein binds to exogenously introduced gene products, resulting in transcriptional activation of a toxic gene. As an example, we show that this approach can be used to specifically kill cells overexpressing a mutant p53 gene in cell culture. The strategy may be generally applicable to neoplastic diseases in which the underlying patterns of genetic alterations or abnormal gene expression are known.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=39510Documentos Relacionados
- Selection for retroviral insertions into regulated genes.
- Direct introduction of genes into rats and expression of the genes.
- Large scale screen for transposon insertions into cloned genes.
- Molecular biology and respiratory disease. 4. Cancer genes.
- Aspergillus fumigatus contamination of lymphokine-activated killer cells infused into cancer patients.